539 related articles for article (PubMed ID: 16984965)
1. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.
Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S
Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965
[TBL] [Abstract][Full Text] [Related]
2. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.
Nohesara S; Ghadirivasfi M; Mostafavi S; Eskandari MR; Ahmadkhaniha H; Thiagalingam S; Abdolmaleky HM
J Psychiatr Res; 2011 Nov; 45(11):1432-8. PubMed ID: 21820670
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
[TBL] [Abstract][Full Text] [Related]
4. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
Lipska BK; Mitkus S; Caruso M; Hyde TM; Chen J; Vakkalanka R; Straub RE; Weinberger DR; Kleinman JE
Hum Mol Genet; 2006 Sep; 15(18):2804-12. PubMed ID: 16905560
[TBL] [Abstract][Full Text] [Related]
5. The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression.
Dempster EL; Mill J; Craig IW; Collier DA
BMC Med Genet; 2006 Feb; 7():10. PubMed ID: 16483362
[TBL] [Abstract][Full Text] [Related]
6. Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.
Silberschmidt AL; Sponheim SR
Schizophr Res; 2008 Mar; 100(1-3):316-24. PubMed ID: 18201871
[TBL] [Abstract][Full Text] [Related]
7. MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls.
Walton E; Liu J; Hass J; White T; Scholz M; Roessner V; Gollub R; Calhoun VD; Ehrlich S
Epigenetics; 2014 Aug; 9(8):1101-7. PubMed ID: 24837210
[TBL] [Abstract][Full Text] [Related]
8. The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.
Lott SA; Burghardt PR; Burghardt KJ; Bly MJ; Grove TB; Ellingrod VL
Pharmacogenomics J; 2013 Jun; 13(3):264-71. PubMed ID: 22391769
[TBL] [Abstract][Full Text] [Related]
9. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia.
Murphy BC; O'Reilly RL; Singh SM
Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):37-42. PubMed ID: 15635661
[TBL] [Abstract][Full Text] [Related]
10. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
[TBL] [Abstract][Full Text] [Related]
11. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
[TBL] [Abstract][Full Text] [Related]
12. Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia.
Hoenicka J; Garrido E; Ponce G; Rodríguez-Jiménez R; Martínez I; Rubio G; Jiménez-Arriero MA; Palomo T
Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):948-54. PubMed ID: 20127886
[TBL] [Abstract][Full Text] [Related]
13. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.
Goghari VM; Sponheim SR
Schizophr Res; 2008 Aug; 103(1-3):186-91. PubMed ID: 18571901
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder.
Abdolmaleky HM; Pajouhanfar S; Faghankhani M; Joghataei MT; Mostafavi A; Thiagalingam S
Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):687-96. PubMed ID: 26285059
[TBL] [Abstract][Full Text] [Related]
15. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype.
Tunbridge EM; Weinberger DR; Harrison PJ
Mol Psychiatry; 2006 Feb; 11(2):116-7. PubMed ID: 16247488
[No Abstract] [Full Text] [Related]
16. Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.
Bortolato M; Walss-Bass C; Thompson PM; Moskovitz J
World J Biol Psychiatry; 2017 Apr; 18(3):247-254. PubMed ID: 27458023
[TBL] [Abstract][Full Text] [Related]
17. COMT: a common susceptibility gene in bipolar disorder and schizophrenia.
Shifman S; Bronstein M; Sternfeld M; Pisanté A; Weizman A; Reznik I; Spivak B; Grisaru N; Karp L; Schiffer R; Kotler M; Strous RD; Swartz-Vanetik M; Knobler HY; Shinar E; Yakir B; Zak NB; Darvasi A
Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):61-4. PubMed ID: 15211633
[TBL] [Abstract][Full Text] [Related]
18. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study.
van der Knaap LJ; Schaefer JM; Franken IH; Verhulst FC; van Oort FV; Riese H
Genes Brain Behav; 2014 Sep; 13(7):618-25. PubMed ID: 24902721
[TBL] [Abstract][Full Text] [Related]
20. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
